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ABSTRACT  We have examined the distribution of microtubute-associated protein 2 (MAP2) in 
the lumbar segment of spinal cord, ventral and dorsal roots, and dorsal root ganglia of control 
and/3,/T-iminodipropionitrile~treated  rats. The peroxidase-antiperoxidase technique was used 
for light and electron  microscopic  immunohistochemical  studies with two monoclonal  anti- 
bodies directed  against different  epitopes of Chinese  hamster brain  MAP2,  designated AP9 
and AP13. MAP2 immunoreactivity  was present in axons of spinal motor neurons, but was not 
detected  in axons of white  matter tracts of spinal  cord and  in the  majority  of axons of the 
dorsal root. A gradient of staining intensity among dendrites, cell bodies, and axons of spinal 
motor neurons was present, with dendrites staining most intensely and axons the least. While 
dendrites and cell bodies of all neurons in the spinal cord were intensely positive, neurons of 
the dorsal root ganglia were variably stained. The axons of labeled dorsal root ganglion cells 
were intensely labeled up to their bifurcation; beyond this point, while only occasional central 
processes in dorsal roots were weakly stained, the majority of peripheral  processes in spinal 
nerves were positive. 
~,/3'-Iminodipropionitrile  produced segregation of microtubules and membranous organelles 
from neurofilaments in the peripheral nervous system portion and accumulation of neurofila- 
ments  in  the central  nervous system  portion  of spinal  motor axons.  While  both  anti-MAP2 
hybridoma antibodies co-localized  with  microtubules  in the central  nervous system portion, 
only one co-localized  with  microtubules  in the  peripheral  nervous system portion  of spinal 
motor axons, while the other antibody co-localized with neurofilaments and did not stain the 
central region of the axon which contained microtubules. These findings suggest that (a) MAP2 
is present in axons of spinal  motor neurons, albeit in a lower concentration  or in a different 
form than is present in dendrites, and (b) the MAP2 in axons interacts with both microtubules 
and neurofilaments. 
Numerous polypeptides co-purify with the microtubule pro- 
tein tubulin through repetitive cycles of temperature-depend- 
ent assembly and disassembly. During this process, those that 
maintain  a  constant  stoichiometry  to  tubulin  have  been 
termed microtubule-associated proteins (MAPs) ~ (1,  2).  The 
~Abbreviations  used  in  this paper: CNS,  central  nervous  system; 
most abundant  MAP in neural tissues is a  heat-stable,  high 
molecular  weight  phosphoprotein  (Mr  ~  300,000)  termed 
MAP2 (see reference 3 for a review). MAP2 stimulates tubulin 
IDPN, B,/3'-iminodipropionitrile; MAP, microtubule-associated pro- 
tein; PEG, polyethylene glycol; PNS, peripheral nervous system. 
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microtubule and thus stabilizing the formed polymer (1). The 
filamentous projections, characteristic of MAP2  binding to 
the  microtubule wall,  are reminiscent of the  side-arms ob- 
served in situ, which seem to connect microtubules to mem- 
branous organelles (4-9) and to other cytoskeletal structures 
such as neurofilaments (8-10). Indeed, MAP2 has been shown 
to co-localize with intermediate flaments in certain cultured 
brain cells (11).  In vitro experiments have demonstrated that 
neurofilaments are  frequent  contaminants  of bovine brain 
microtubule preparations and one of the proteins associated 
with these cytoskeletal structures is MAP2  (12).  It has also 
been shown that  MAP2  produces a  20-fold increase in  the 
viscosity of an ATP-induced complex between microtubules 
and neurofilaments (13).  Furthermore, under certain condi- 
tions, MAP2 can be competed off from microtubule prepa- 
rations  in  vitro by the  addition  of neurofilaments (14).  In 
addition to its interaction with microtubules and neurofda- 
ments in vitro, MAP2 also binds to actin filaments, causing 
gelation and bundling of the actin filaments (15-18). There- 
fore, even though MAP2 is defined as a microtubule-associ- 
ated protein based on its tubulin binding capacity in vitro, its 
in vivo association(s) in the various cell types of neural tissues 
and different cell compartments of individual neurons remain 
unclear. 
Biochemical and immunocytochemical studies have dem- 
onstrated that MAP2 is most abundant,  but not exclusively 
restricted  to  neurons  (19-24).  Furthermore,  immunohisto- 
chemical studies have shown that in neurons MAP2 is pref- 
erentially distributed  in  dendrites and  cell bodies and  it  is 
undetectable in axons (25-28). In addition, axonal transport 
experiments, performed in the guinea pig optic system, have 
reproducibly  failed to  detect  transport  of any  proteins  co- 
migrating with MAP2 on SDS-polyacrylamide gels (29).  By 
contrast, a recent report has shown MAP2 immunoreactivity 
in certain axons within the central nervous system (CNS) (30). 
Moreover, data have been obtained from biochemical studies 
on taxol-stabilized microtubules assembled from extracts of 
bovine cortex (gray matter) and corpus callosum (white mat- 
ter). These results have shown that,  although the  MAP2 to 
tubulin ratio is five times lower in the white matter microtu- 
bule preparations than in those obtained from gray matter, 
significant amounts of MAP2 exist in either the axons or glia 
of white  matter  (31).  Due  to  these  seemingly  conflicting 
reports, the presence or absence of MAP2 in, at least, certain 
groups of axons remains unresolved. 
To further investigate the cellular and subcellular localiza- 
tion of MAP2 and its possible role in microtubule-neurofila- 
ment interactions, we have examined its distribution in con- 
trol  and  ~,/3'-iminodipropionitrile  (IDPN)-treated  axons. 
Administration of IDPN, a synthetic neurotoxic compound, 
to rats selectively and severely impairs the axonal transport 
of neurofilament proteins, but causes no impairment of the 
transport of tubulin and actin (32,  33).  Also the fast antero- 
grade  and  retrograde  transports,  which  carry membranous 
organelles, remain relatively normal (32,  34).  This impedi- 
ment to the transport of neurofilament proteins results in an 
accumulation of neurofilaments in  the CNS portion of the 
spinal motor neurons (35,  36), beginning at the CNS-periph- 
eral nervous system (PNS) junction and proceeding towards 
the cell body (33).  In the PNS portion of these motor axons, 
contemporaneously with the cessation of transport of neuro- 
filament  proteins,  IDPN  produces  a  reorganization  of the 
axoplasmic organelles resulting  in  segregation of neurofila- 
ments to the cortical axoplasm, and of microtubules, mito- 
chondria, and a large portion of smooth endoplasmic reticu- 
lum to the central region of the axon (37-39). 
This highly reproducible segregation of two of the  major 
filamentous elements of  the cytoskeleton provides an excellent 
model system in which to study the subcellular distribution 
of the accessory proteins known to associate with microtu- 
bules in vitro and their role in axonal transport. Using this 
"IDPN model" we have examined the localization of MAP2 
within spinal motor axons before and after IDPN administra- 
tion.  We have utilized two monoclonal antibodies directed 
against different epitopes of MAP2, one monoclonal antibody 
against ~3-tubulin, an affinity-purified polyclonal antibody to 
or- and/3-tubulin, and an antiserum against the 68,000-dalton 
subunit of neurofilaments. Using the peroxidase-antiperoxi- 
FIGURE  I  Immunoblots  of an SDS extract of rat spinal cord, stained 
with the monoclonal antibodies against MAP2  (APt 3 in lane B and 
AP9  in lane C) and b'-tubulin (lane  D),  using the peroxidase-anti- 
peroxidase technique. Arnido black staining was used  for protein 
visualization (lane A). The positions of molecular weight standards 
are marked on the left, while the positions of MAP2 and/~-tubulin 
(l~Tu) standards are indicated on the right. 
PAPASOZOMENOS ET AL,  Binding  of MAP2  75 dase  technique  for both  light and  electron  microscopic im- 
munohistochemistry, we demonstrate that (a) both antibodies 
to MAP2 stain the axons of spinal motor neurons and, (b) in 
IDPN-treated rats, both antibodies to MAP2 co-localize with 
microtubules in the CNS portion but,  in the PNS portion of 
spinal  motor axons,  one anti-MAP2  antibody  localizes with 
neurofilaments  while  the  other  continues  to  localize  with 
microtubules. Part of this work has appeared in abstract form 
(40). 
MATERIALS  AND  METHODS 
Antibodies:  Preparation and characterization ofmonoclonai antibodies 
against Chinese  hamster brain MAP2, designated  AP9 and AP 13, and ~/-tubulin, 
designated Tu9B, and of  rabbit affinity-purified  polyelonal  antibodies to bovine 
brain c~- and  8-tubulin have been described in detail (30, 41, 42). For the 
present study, the specificities  of the monoclonal antibodies to MAP2 and 8- 
tubulin were  tested on nitrocellulose  immunoblots of homogenates of rat spinal 
cord and are shown in Fig. 1. Immunobiots were accompSshed using SDS-urea 
polyacrylamide gels (43, 44) which were transferred to nitrocellulose  (45), and 
the antigens observed using the pcroxidase-antiperoxidase  technique (46, 47). 
FIGURE  2  Sections from control rat immunostained with AP9 (a and c) and Ap13 (b and d). (a) Paraffin-embedded cross section 
of spinal cord and ventral root. gin, gray matter; win, white matter. Arrowheads and arrows point to the CNS-PNS  junction and 
CNS portion of motor axons, respectively. Dendrites, cell bodies and axons of motor neurons are strongly stained. AP9 (1.5/zg/ 
ml). Bar,  100/~m. x  125.  (b) Epon-embedded section of gray matter of spinal cord. The cell bodies (cb) of motor neurons show 
patchy positivity and  the dendrites (d) are intensely stained. AP13  (39 ,ug/ml). Bar, 25/~m.  x  500.  (c and d)  PEG-embedded, 
longitudinal (c) and cross (d) sections of ventral roots. Axons are strongly positive. Section (c) was kept floating in tissue culture 
well and section (d) was mounted on glass slide during immunostaining. (c) AP9 (0.370/~g/ml). (d) AP13 (3.9 ~g/ml). Bars, 30 ~m. 
(c) x  400. (d) x  500. 
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visualized with amido black staining (45). As has been shown (48), AP9 and 
API3 are directed against different epitopes on the MAP2 molecule. All three 
hybridoma antibodies are IgG~ and their immunoglobulin concentrations  prior 
to dilution  (determined  as has been described elsewhere [30]) were AP9 0.37 
mg/ml; API3 0.39 mg/ml; Tu9B 0.39 mg/ml. For immunohistochemistry,  the 
antibodies to MAP2 and ~-tubulin were used as hybridoma  culture supernatants 
at dilutions of l:100-1:l,000. 
The polyclonal antibody  to a- and ~/- tubulin was used at a concentration 
of l0 gg/ml and its specificity has becn described (42). The characterization  of 
rabbit antiserum against the 68,000-dalton subunit of rat neurofilaments (a gift 
from Dr. P.  Gambetti,  Div. of Neuropathology,  Institute  of Pathology, Case 
Western Reserve University) has been reported (49) and was used at dilutions 
of 1:750-1:2,000. 
Preadsorption of anti-MAP2 antibodies was performed using purified, heat- 
stable bovine brain MAP2 attached  to an Affi-Gel l0 matrix  (Bio-Rad, Rich- 
mond, CA). A l0 times concentrated hybridoma  culture supernatant  was loaded 
onto the resulting column and the "flow through" was collected. The protein 
concentration  of the "flow through" peak was adjusted to that in the column 
load. The absence of mouse IgG was determined  by double immunodiffusion 
against a rabbit antimouse IgG polyclonal antiserum, 
IDPN Administration:  Male Sprague-Dawley rats weighing 200-250 
g were given 2 mg/g body weight of IDPN (Eastman  Kodak, Rochester, NY), 
divided into four equal doses and given every 3 d by intraperitoneal  injection. 
IDPN was diluted  1:5 in saline and the pH adjusted to 7.4 with hydrochloric 
acid. Controls received similar injection of saline. 
FiGure  3  Electron micrographs of vibratome sections of lumbar region of spinal cord of a control rat, immunostained with AP13 
(0.78 #g/ml). While microtubules in dendrites {d) and cell bodies (cb) of motor neurons are intensely stained, nearby myelinated 
axons (ax) and axonal terminals (axt) are negative. In cell bodies of motor neurons, staining is present in domains of microtubules 
and mitochondria and is almost absent from domains of Nissl  bodies (Nb), as is shown in a and b. Neuronal nuclei (nu), glial cells 
(g) and blood vessel walls {by) are negative. Bars: (b and d) 1 /~m, (c) 2/~m, (a) 4/zm. (a) x  3,120; (b) x  15,200; (c) x  6,760; (d) x 
12,825. 
PAPASOZOMENOS  ET  AL.  Binding  of MAP2  77 lrnmunohistochernistry:  Control and IDPN-treated  rats were sacri- 
riced 2 and 4 d,  1-4, and 6 wk after the fourth  injection.  Under Nembutal 
anesthesia,  the  animals  were  peffused  transeardially  with  a  brief wash  of 
phosphate-buffered saline followed by 800 ml of a mixture of 4% paraformal- 
dehyde and 0.25% glutaraldehyde,  in  120 mM sodium potassium  phosphate 
buffer (pH 7.4) at 37°C. Tissue samples were further fixed in 4% paraformal- 
dehyde at 4°C for either another one hour for light microscopy or overnight for 
light and electron microscopy. Tissue samples, were taken from the lumbar (L) 
segment of spinal cord, the L5 ventral and dorsal roots and the L3, I_4, and L~ 
dorsal root ganglia, the sciatic and optic nerves and from several other areas of 
FIGURE 4  Ls dorsal root ganglia immunostained  with AP9. (a) Light micrograph of an Epon-embedded  section. Intensely stained, 
negative, and ganglion cells with intermediate staining intensity are present. Arrows  point to strongly labeled axons. AP9, 0.37 
#g/ml.  Bar, 30 pm.  x  500. (b) Electron micrograph  of a vibratome section. Three ganglion cells (gc)  show patchy cytoplasmic 
immunoreactivity and two axons (arrows) are intensely stained. Satellite cells (sc), which surround  ganglion cells, are negative 
(arrowheads). AP9, 0.74 pg/ml.  Bar, 2 pm. x  7,500. 
FIGURE 5  Parrafin-embedded  section of a dorsal root ganglion and attached ventral root immunostained with AP9 (1.5/~g/ml). 
Groups of ganglion cells with various degrees of staining intensity are seen. Note the difference between the positive peripheral 
processes (pp), which together with the stained motor axons of ventral root (vr) form the spinal nerve, and the negative central 
processes (cp), which constitute the dorsal root. Bar, 100 pm. x  160. 
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polyethylene  glycol (PEG) and paraffin, or sections were cut on a vibratome 
without prior embedding. PEG-embedding  was done in a mixture of 4 parts of 
1,000-mol vet PEG to  1 part 3,350-mol wl PEG (Sigma Chemical Co., St. 
Louis, MO) (50). Light microscopic  immunostaining  was performed on 3-, 4-, 
and 6-urn  thick sections  cut from Epon-, PEG-, and paraffin-embedded  tissues, 
respectively. PEG-embedded sections were mounted on poly-L-lysine-coated 
glass slides  (51). Epon-embedded  sections  were treated with sodium methoxide 
to remove the Epon (52) before immunostaining. For electron microscopic 
immunostaining, 30- or 40-~m thick vibratome or 6-tLm  thick PEG-embedded 
sections  were used. 
The peroxidase-antiperoxidase  technique (46, 47) was used for immuno- 
staining. Sections mounted on glass slides or free-floating  sections were im- 
munostained  by incubating with (a)  10% normal goat (Miles Laboratories, 
Elkhart, IN) or rabbit (Sternberger-Meyer,  Jarrettsville,  MD) serum, depending 
on the species of the secondary antibody, to reduce nonspecific  staining; (b) 
primary antibody, for 18-36 h at 4"C; (c) goat anti-rabbit IgG, diluted 1:50 
(Cappel Laboratories, West Chester, PA), or rabbit anti-mouse IgG, diluted 
1:40 (Sternberger-Meyer,  Jarrettsville,  MD); (d) rabbit peroxidase-antiperoxi- 
dase, diluted 1:200  (Cappel Laboratories, West Chester, PA), or mouse perox- 
idase-antiperoxidase  prepared from monoclonal  antibody,  diluted 1:150  (Steru- 
berger-Meyer,  Jarrettsville,  MD);  and (e) 0.075% diaminobenzidine  tetrahydro- 
chloride  and 0.015  % hydrogen  peroxide  in 50 mM Tris-HCl, 10 mM imidazole, 
pH 7.6, for 2-5 min. Incubation times for steps (a), (c), and (d) were 30 rain 
for sections  6 gm thick or less and 90 min for vibratome  sections.  Dilutions of 
all antibodies  and washings  between steps (b) and (c), and between  (c) and (d) 
were done with 1% normal goat or rabbit serum in 50 mM Tris-HCl,  0.15 M 
sodium chloride, pH 7.6. Specificity  of staining was determined by absorbing 
the primary antibodies with a  molar excess of the specific antigen and by 
incubating  with nonimmune, or 1% normal goat or rabbit sera in 50 mM Tris- 
HCI, 0.15 M sodium chloride, pH 7.6. 
Following  immunostaining,  sections  for electron  microscopy  were osmicated 
in  1%  OsO4 for  30  min, dehydrated in graded alcohols, passed through 
propylene  oxide,  and fiat-embedded  in Epon according  to standard procedures. 
Ultrathin sections  were picked up on uncoated grids and viewed  without prior 
staining with heavy metals. 
RESULTS 
Localization of MAP2 Immunoreactivity  in 
Control Rats 
The localizations of two anti-MAP2 antibodies AP9, and 
AP13,  were  studied  at  the  light  and  electron  microscopic 
levels in the lumbar region of spinal cord and ventral roots 
and in the dorsal root ganglia and dorsal roots. 
SPINAL  CORD  AND  VENTRAL  ROOTS:  In  the  spinal 
cord, both AP9 and AP 13 intensely stained dendrites and cell 
bodies of all neurons. A patchy reaction pattern was obtained 
in cell bodies of motor neurons and no immunoreactivity  was 
present in nuclei (Figs. 2, a  and b, and 3). In addition, both 
antibodies strongly stained the CNS and PNS (ventral root) 
portion  of motor  axons  (Fig.  2,  a,  c,  and  d).  However,  a 
gradient of staining intensity was  present among dendrites, 
neuronal cell bodies and axons of motor neurons, with den- 
drites  staining most  intensely and  axons  the  least.  In  em- 
bedded tissues, while both AP9  and AP13  stained axons of 
spinal  motor  neurons  rather  strongly,  axons  in  the  white 
matter tracts of spinal cord were negative (Figs. 2 a  and 10 b). 
In vibratome sections, which  were  immunostained without 
prior dehydration and embedding, AP9, but not AP 13, occa- 
sionally stained axons in the white matter,  but the reaction 
was too weak and inconsistent to be reliably interpreted. In 
general, with the same antibody concentration, AP9 produced 
a  more intense staining of axons than AP13. 
DORSAL  ROOT  GANGLIA  AND  DORSAL  ROOTS;  In 
dorsal root ganglia, a  mosaic staining pattern prevailed. Neu- 
rons with intense cytoplasmic staining were intermixed with 
negative neurons and neurons with intermediate intensity of 
staining (Figs. 4  and 5).  While most of the intensely stained 
neurons were large and the unlabeled were small, several large 
neurons  were  negative  and  several  small  neurons  were 
strongly positive. The pseudounipolar, axonal process of la- 
beled ganglion cells was intensely stained up to its bifurcation 
(Fig.  4),  and, in general, the  staining of the  axonal process 
was stronger than that of the cell bodies. Beyond the bifurca- 
tion point, while positive immunoreaction was  observed in 
the peripheral processes, which project into the spinal nerve, 
no staining was present in the central processes, which con- 
stitute the  dorsal  root  (Figs.  5  and  6).  However,  in  a  few 
experiments, there was weak staining in occasional, relatively 
large axons of dorsal root. Differential staining of dorsal root 
ganglion cells was also obtained with the antibody to B-tubulin 
and  the  antiserum  to  68,000-dalton  subunit  of  neurofda- 
ments,  but  with  these  antibodies,  if  the  cell  bodies  were 
labeled, intense immunoreactivity was present in both their 
central and peripheral processes (data not shown). 
Electron  microscopic  immunohistochemistry  confirmed 
and extended the light microscopic findings (Figs. 3, 4b, and 
9 a). In cell bodies of motor neurons, domains of Nissl bodies 
remained largely unstained, while regions occupied mostly by 
microtubules and mitochondria were  strongly positive (Fig. 
3, a  and b). Thus, the patchy pattern of immunoreactivity in 
neuronal cell bodies seen with light microscopy (Fig.  2 b) is 
largely due to  lack of immunoreactivity in Nissl bodies.  A 
similar, but less pronounced,  staining pattern  was  also  ob- 
served in dorsal root ganglion cells. The staining intensity was 
further increased in dendrites of spinal neurons and in the 
axonal processes of labeled dorsal root ganglion cells (Figs. 3, 
a, c, and d, and 4). In these neuronal processes and in axons 
of spinal motor neurons (Fig. 9 a) both AP9 and AP13 deco- 
rated microtubules in cross and longitudinal sections. Mito- 
chondria were negative. In contrast to the presence of intense 
immunoreactivity  in  dendrites  and  neuronal  cell  bodies, 
nearby, apparently nonmotor, myelinated axons and axonal 
FIGURE  6  A paraffin-embedded longitudinal section of the Ls dor- 
sal root ganglion with its dorsal root (dr)  and attached ventral root 
(vr), immunostained  with AP9 (I .5 ~glml). While axons of the ventral 
root are positive, those of the dorsal root are negative. Bar, 60/~m. 
x  250. 
PAPASOZOMENOS  ET  AL  Bindine  of MAP2  79 FIGURE  7  Light micrographs of adjacent, Epon-embedded (a-d) and serial PEG-embedded sections (e-f) of Ls ventral root, 2 wk 
after  IDPN  administration, immunostained with various antibodies. (a) Antiserum to 68,000-dalton  subunit of  neurofilaments, 
diluted 1:2,000; only the cortical axoplasm is intensely stained; a single or occasionally two or more, smaller, unstained, central 
areas are present, x  500. (b) Affinity-purified, polyclonal antibody against ~- and fl-tubulin (10 p.g/ml). Only the central region of 
axons is strongly positive and a complementary staining pattern to that obtained with antineurofilament serum is seen. x  500. (c) 
API 3 (3.9/~g/ml) stained only the cortical axoplasm; it produced a similar staining pattern to that obtained with antineurofilament 
serum,  x  500.  (d)  Adsorption  of  APt3  on  a  MAP2  affinity  column  abolished  staining  of  axons,  x  500.  (e  and  f)  Both  the 
antineurofilament serum (e),  diluted  1:1,000,  and AP13  (3.9 p.g/ml) (f), stained only the cortical axoplasm, x  500.  None of the 
above antibodies stained the myelin sheaths, blood vessel walls or connective tissues.  Bars, 30/~m. 
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Astrocytes and oligodendrocytes, ependymal, satellite, and 
Schwann  cells  were  negative  for  MAP2  immunoreactivity 
(Figs.  3,  a  and c,  and 4b).  Only the astrocytes in the optic 
nerve and tract were strongly positive (data not shown). The 
capillary endothelium, pericytes and vascular smooth muscle 
cells also remained unstained. 
In all  sections there  was no  immunoreactivity when  ab- 
sorbed or nonimmune sera were used. 
Iramunohistochemical  Studies of IDPN-treated 
Spinal Motor Axons 
PNS  PORTION:  IDPN produced  reorganization of axo- 
plasmic organeUes,  with displacement of neurofilaments to- 
wards  the  periphery  and  of  microtubules,  smooth  endo- 
plasmic reticulum and mitochondria towards the central re- 
gion of the PNS portion of motor axons. Thus, the antiserum 
to 68,000-dalton  subunit of neurofilaments stained only the 
peripheral axoplasm,  occupied by neurofilaments (Fig.  7,a 
and e), and both the affinity-purified, polyclonal antibody to 
a- and fl-tubulin (Fig.  7 b) and the monoclonal antibody to 
fl-tubulin  (Fig.  8)  localized  only with  microtubules  in  the 
central region of axons. With the antibodies to tubulin, most 
of the axons showed a single stained area in the central region, 
although  in  a  few axons,  two  or  more  smaller,  separately 
labeled  areas  were  present.  This  staining  pattern  obtained 
with  the  antibodies  to  tubulin  was complementary to  that 
obtained with the antineurofilament serum. The above im- 
munoreactivity patterns, demonstrating segregation of micro- 
tubules from neurofilaments were observed along the entire 
length  of the  sciatic  nerve.  It is worth  noting here that,  in 
IDPN-treated axons, both a- and fl-tubulin and the 68,000- 
dalton subunit of neurofilaments are found only where mi- 
crotubules and neurofilaments are present, respectively, and 
not diffusely over the entire cross-section of the axons. 
In IDPN-treated motor axons, different localizations were 
observed with the two antibodies against MAP2; while AP9 
localized with  microtubules in  the  central  region  of axons 
(Fig.  9 b), which  were frequently surrounding  membranous 
organelles, API 3 localized with neurofilaments at the cortical 
axoplasm and no staining of microtubules was obtained (Figs. 
7 c and f, and 9 c). To rule out the possibility of nonspecific 
binding of API 3 to aggregated neurofilaments, sections were 
treated with alkaline (pH 9.5) Tris-buffered saline, following 
incubation  with  AP13,  but  no  diminution  in  the  staining 
intensity was  observed (53).  In addition,  pre-adsorption  of 
API3 on a MAP2 affinity column, performed as is described 
under  Materials and  Methods,  abolished  staining  of axons 
(Fig. 7d). 
CNS PORTION:  The CNS portion of a spinal motor axon 
is the segment of the axon whose myelin sheath is formed by 
oligodendrocytes, in  contrast to  Schwann  cells in  the  PNS 
portion, and is included in the blood-brain barrier. It usually 
projects for a very short distance into the ventral root, as is 
well illustrated in Figs.  2a and  10b. This portion of IDPN- 
treated motor axons was dilated, tortuous and filled with an 
increased number of  neurofilaments (Figs. l0 a and 11). There 
was no apparent accumulation of microtubules, which were 
spread  over the  entire  cross-section  of the  axon,  and  no 
segregation of microtubules from neurofilaments was present 
(Fig.  1  l). In cross and longitudinal sections of this portion of 
IDPN  axons,  both  antibodies  to  MAP2  co-localized  with 
microtubules, while neurofilaments remained unstained (Figs. 
10b and l l). 
DISCUSSION 
The presence or absence of MAP2 in axons is a controversial 
issue. Biochemical studies demonstrated significant quantities 
FIGURE 8  Electron micrographs of PEG-embedded (a) and vibratome (b) sections of Ls ventral root, 2 wk after IDPN administra- 
tion. Both sections were immunostained with the monoclonal antibody against/~-tubulin  (I ~g/ml in a and 0.39 #glml in b). In a, 
only the central  region of axons,  occupied by  microtubules is  strongly  positive,  while the cortical  axoplasm,  occupied  by 
neurofilaments, remained unstained.  The Schwann cell cytoplasm  (arrow)  is also positive,  x  2,730.  In b,  six small groups of 
microtubules (MT) in the central region of this axon are intensely stained, while the segregated neurofilaments (NF) are negative. 
x  18,050. Bars: (a) 5 ~m; (b) I /~m. 
PAPASOZOMENOS  ET AL.  Binding  of MAP2  81 FIGURE  9  Electron  micrographs of vibratome sections  (a and b), 
immunostained with AP9 (1.5 ttg/ml), and PEG-embedded section 
(c) immunostained with AP13 (0.74 ~g/ml). my, myelin sheath; m, 
mitochondria. (a) Ls ventral root of a control rat. Only microtubules, 
that are distributed over the entire cross section of this myelinated 
axon, are stained, x  15,200. (b) L5 ventral root, 4 d following IDPN 
administration. Only microtubules, which are mostly found at the 
central region of the axon, are decorated; neurofilaments (NF) are 
negative, x  15,200. (c) L5 ventral root, 2 wk after IDPN administra- 
tion.  AP13 localized with segregated  neurofilaments (NF) at the 
periphery of this myelinated axon, while microtubules (MT),  mito- 
chondria, and  profiles of smooth endoplasmic reticulum are un- 
stained, x  15,200.  Bars, 1 /~m. 
82  THE JOURNAL OF  CELL BIOLOGY • VOLUME 100,  1985 
of MAP2 in microtubules purified from bovine white matter 
tracts (31), however, a number ofimmunocytochemical stud- 
ies do not support this finding (25-28). In a recent report, in 
which  the  same  monoclonal  antibodies  employed  in  our 
present study were used, MAP2 immunoreactivity has been 
demonstrated in certain CNS axonal tracts (30). In agreement 
with these findings, we have found MAP2 immunoreactivity 
in some, but not all axons that we examined. 
Monoclonal antibodies are exquisitely specific probes which 
recognize discrete binding domains on proteins. Should their 
conjugate epitopes be in some way altered or masked, little 
or no reaction will be observed. Therefore, a negative immu- 
nostaining reaction does not necessarily prove the absence of 
the target polypeptide. By extension, should the same epitope 
be present on a polypeptide other than the immunogen, the 
monoclonal antibody will  not  distinguish  between the  two 
proteins and false positives are possible. In fact, unexpected 
cross-reactivities with monoclonal antibodies have been re- 
ported (54-57). Our monoclonal antibodies bind to only the 
MAP2 doublet when assayed by either nitrocellulose blotting 
procedures of whole spinal cord extracts (Fig.  1) or immu- 
noprecipitation of whole brain extracts (Black, M. M., and L. 
I. Binder, in preparation). By these criteria, they are "mono- 
specific."  However,  the  caveat  that  axonal  staining  could 
represent cross-reactivity with a  non-MAP2 species can not 
be  ruled  out,  although  the  localization  of the  anti-MAP2 
antibodies with microtubules at the electron microscope level 
renders this possibility very unlikely. 
Therefore, differential staining of various axonal popula- 
tions by AP9  and  API3  indicates that  either (a)  MAP2  is 
present in some axons but not in others or, (b) different types 
of axons contain different forms of MAP2.  Different forms 
of MAP2 could be defined by a masking of specific epitopes 
due  to  interactions  with  other  axonal  proteins  or  by  the 
modification of the  epitope,  e.g.,  by phosphorylation  (58), 
rendering it incapable of antibody binding. Our current results 
do  not  distinguish  between  these  possibilities.  Differential 
axonal staining using the anti-MAP2 antibodies was especially 
evident when the strong immunoreactivity in motor axons of 
ventral root was compared with the lack of staining in sensory 
axons in dorsal root and in the white matter tracts of spinal 
cord. It became also apparent when the peripheral and central 
processes of the dorsal root ganglion cells were examined. The 
peripheral processes, which project into the spinal nerves and 
resemble axons both physiologically and morphologically, but 
function as dendrites in that they receive information, exhib- 
ited strong immunoreaction. In contrast, the central processes 
which form the dorsal root and not only resemble axons but 
also  function  as  axons  showed  no  staining.  This  staining 
pattern  resembles that  seen  in  CNS  neurons  in  which  the 
axons either lack MAP2  immunoreactivity or exhibit  only 
light  staining,  while  the  dendrites  are  heavily  stained.  In 
addition, the fact that the dorsal root ganglion cells constitute 
a heterogeneous cell population (59-63) has also been amply 
demonstrated in our study by using anti-MAP2 antibodies. 
In our model of acute administration of IDPN, neurofila- 
ments accumulate in the CNS portion of spinal motor axons, 
since their synthesis in the neuronal perikarya and export into 
the axon continues unimpaired (64),  while they can not be 
transported beyond the CNS-PNS junction. Microtubules do 
not accumulate to any appreciable extent and previous work 
indicates that any impediment to the transport of tubulin is 
secondary to the marked accumulation of neurofilaments (32, FIGURE 10  (a) Epon-embedded section  of Ls segment of spinal cord,2 wk after IDPN administration, immunostained with the 
antiserum against the 68,000-dalton  subunit of neurofilaments,  diluted 1:1,000. gin, gray matter;  win,  white matter.  The CNS 
portions of motor axons are enlarged, tortuous and intensely stained (small arrows). The big arrow points to a motor neuron with 
weak cytoplasmic and dendritic staining and intense staining of its axon; an early axonal swelling (arrowhead) has appeared. Note 
how abruptly the staining intensity increases just after the axon hillock. Axons of white matter tracts are strongly positive.  Bar, 60 
~.m. x  250. (b) Paraffin-embedded section  of lumbar spinal cord and ventral root, 1 wk after IDPN administration.  AP9 (1.5 ;sg/ 
ml) stained strongly  both the dilated CNS portion (arrow), which outpouches into the ventral root, and PNS portion of motor 
axons. The arrowheads delineate the CNS-PNS junction. Bar, 120/~m. X 125. 
FIGURE 11  Electron micrographs  of vibratome sections of the dilated CNS portion of motor axons (max), immunostained with 
AP9 (0.74 #g/ml)  in a and AP13 (0.78/sg/ml)  in b. Both AP9 and AP13 localized with microtubules in cross (a) and longitudinal 
sections (between arrowheads in b). Mitochondria (m) and other membranous organeltes are not stained. While nearby dendrites 
(d) are intensely positive,  myelinated axons (ax)  of white matter tracts are negative. Sections were not counterstained with heavy 
metals, my, myelin sheath. Bars: (a) 2 #m; (b) 1 #m. (a) x  6,230; (b) x  10,880. 
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with them in the PNS portion of IDPN-treated axons, one 
would expect MAP2 to accumulate with the neurofilaments 
on the CNS side of the CNS-PNS junction, if the association 
of MAP2 with neurofilaments was independent of microtu- 
bules.  Our immunocytochemical data indicate  that  MAP2 
does not accumulate but rather is present in apparently nor- 
mal amounts in proportion to the number of microtubules 
observed. These findings show that MAP2 is associated with 
microtubules and  is  transported  down  the  axons  past  the 
CNS-PNS junction. However, MAP2 associated with micro- 
tubules in the PNS portion is qualitatively different from that 
in the CNS portion of motor axons, since it has available only 
the AP9 epitope whereas, MAP2 on the CNS side will bind 
both AP9 and AP 13. 
The localization of MAP2 with segregated neurofilaments 
in the PNS portion of motor axons is reminiscent of the study 
by Bloom and Vallee (11), who have found that in cultured 
brain  cells,  following  depolymerization  of  microtubules, 
MAP2 co-localizes with cables of vimentin filaments. In our 
study, only AP9 stained microtubules in the PNS portion of 
spinal  motor axon after IDPN  administration, while API3 
localized with neurofilaments. The reason for this is intrigu- 
ing, because AP9  and AP13  bind different epitopes on the 
MAP2  molecule (48).  The segregation of these epitopes by 
IDPN treatment can be explained by several hypotheses. The 
most  straight  forward  interpretation  involves  the  cleavage 
(presumably by a protease) of the MAP2  molecule between 
these epitopes. This hypothesis presupposes that one end of 
the MAP2 molecule interacts with neurofilaments while the 
opposite  end  associates with  microtubules.  The  possibility 
that  IDPN  induces  a  biochemical  rather than  a  structural 
alteration of the MAP2 molecule should also be considered. 
While  phosphorylation  of  MAP2  enhances  its  affinity  to 
neurofilaments (13, 65), it inhibits its interactions with micro- 
tubules (66,  67),  actin  filaments (15,  16,  18),  and secretory 
granules (6, 7). In addition, a recent report showed that axonal 
neurofilaments become progressively phosphorylated as they 
are transported away from the cell body (58).  Whether the 
states of phosphorylation of MAP2  and neurofilament pro- 
teins define the stability of interactions with each other and 
with other organelles, and if IDPN interferes with the phos- 
phorylation process of these polypeptides remains to be seen. 
In this context, it is worth noting the relative immunity of the 
CNS portion of motor axons to IDPN. Whether this is due to 
a different composition or organization of their cytoskeleton 
or to a  slower rate of accessibility of IDPN, because of the 
presence of blood-brain barrier,  could not yet be answered. 
However,  all  of these  theoretical  considerations are  highly 
speculative and elucidation of the mechanisms involved in 
differential MAP2 sequestration by IDPN requires more ex- 
perimentation. 
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